Emerson has made an equity investment in Fluxa, whose Process & Knowledge Management (PKM) software seamlessly manages product and process specifications throughout the drug development lifecycle.

The acquisition of Fluxa’s PKM ™ software will provide customers a unique solution, integrated with Emerson’s industry leading DeltaV ™ control system and life sciences automation software, accelerating the development of new drug therapies into production.

Fluxa’s PKM™ software is a web-based application that seamlessly manages product and process specifications throughout the drug development lifecycle. Inherently designed to facilitate collaboration, it enables global sites, functions, CDOs, CMOs, and CDMOs, to work together to scale recipes and execute technology transfers.

收购完成后，Fluxa公司的过程与知识管理软件（PKM™）将与艾默生业界前沿的DeltaV TM 控制系统，以及生命科学自动化软件进行整合，为客户提供有针对性的解决方案，从而加快新药疗法的研发投产。

Fluxa’s PKM™ software is a web-based application that seamlessly manages product and process specifications throughout the drug development lifecycle. Inherently designed to facilitate collaboration, it enables global sites, functions, CDOs, CMOs, and CDMOs, to work together to scale recipes and execute technology transfers.

2021年2月25日 · Fluxa PKM, coupled with Emerson’s DeltaV and Syncade systems and Bio-G software, will establish a unique solution and competitive offering to further enable customers to streamline their ...

Bolstered by its acquisition of the Fluxa PKM™ solution and AspenTech’s software capabilities including AspenTech DataWorks industrial information management software, Emerson is well positioned to develop the technologies and standards for a fully integrated end-to-end solution for the drug development pipeline.

2022年7月19日 · Fluxa 通过帮助药物开发和制造组织利用跨站点、功能和流程的协作和数据的力量，加快了新疗法的上市速度。 收购 Fluxa 的 PKM 软件将为客户提供独特的解决方案。

2022年7月5日 · The acquisition of Fluxa’s PKM™ software will provide customers with a unique solution, integrated with Emerson’s industry-leading DeltaV™ control system and life sciences automation software, accelerating the development of new drug therapies into production.

2022年7月8日 · The acquisition of Fluxa’s PKM software will provide customers a unique solution, integrated with Emerson’s industry leading DeltaV control system and life sciences automation software, accelerating the development of new drug therapies into production.